TriSalus Life Sciences (TLSIW) Operating Expenses (2022 - 2025)
Historic Operating Expenses for TriSalus Life Sciences (TLSIW) over the last 4 years, with Q3 2025 value amounting to $11.8 million.
- TriSalus Life Sciences' Operating Expenses rose 3229.38% to $11.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $37.3 million, marking a year-over-year decrease of 1081.97%. This contributed to the annual value of $35.7 million for FY2024, which is 3316.59% down from last year.
- According to the latest figures from Q3 2025, TriSalus Life Sciences' Operating Expenses is $11.8 million, which was up 3229.38% from $9.6 million recorded in Q2 2025.
- In the past 5 years, TriSalus Life Sciences' Operating Expenses ranged from a high of $18.5 million in Q3 2023 and a low of $288273.0 during Q2 2022
- In the last 4 years, TriSalus Life Sciences' Operating Expenses had a median value of $9.2 million in 2023 and averaged $9.2 million.
- As far as peak fluctuations go, TriSalus Life Sciences' Operating Expenses surged by 398709.8% in 2023, and later plummeted by 5172.41% in 2024.
- Over the past 4 years, TriSalus Life Sciences' Operating Expenses (Quarter) stood at $10.3 million in 2022, then surged by 33.49% to $13.8 million in 2023, then plummeted by 44.75% to $7.6 million in 2024, then skyrocketed by 55.42% to $11.8 million in 2025.
- Its last three reported values are $11.8 million in Q3 2025, $9.6 million for Q2 2025, and $8.3 million during Q1 2025.